Blood Sample Collection System - ANVISA Registration 80228990121
Access comprehensive regulatory information for Blood Sample Collection System in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80228990121 and manufactured by SMITHS MEDICAL ASD, INC. The registration is held by ICU MEDICAL DO BRASIL PRODUTOS HOSPITALARES LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including EDWARDS LIFESCIENCES LLC, ICU MEDICAL INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80228990121
25351062232201708
06019570000100
Company Information
Dates and Status
Mar 01, 2017
VIGENTE
09/18/2025 19:00:01
EDWARDS LIFESCIENCES LLCโข United States of America
ICU MEDICAL INC.โข United States of America
ICU MEDICAL DE MรXICO, S.A. DE C.Vโข Mexico
AESKU DIAGNOSTICS GMBH & CO. KGโข Germany
YOURBIO HEALTH, INC.โข United States of America
Sistema para Coleta de Amostra de Sangue
AESKUCAREยฎ Blood Sampling Pouch
AESKU DIAGNOSTICS GMBH & CO. KG
80105229001
Jul 21, 2025
Sistema para Coleta de Amostra de Sangue
BloodTAP - Dispositivo de Coleta de Sangue TAP II
YOURBIO HEALTH, INC.
82454019001
Sep 02, 2024
Sistema para Coleta de Amostra de Sangue
Suporte para Tubo de Coleta de Sangue com Agulha EasyPointยฎ
RETRACTABLE TECHNOLOGIES INC.
10301169007
Jan 22, 2024
Sistema para Coleta de Amostra de Sangue
KMP All Safe-Sistema fechado p/coleta de amostras de sangue para exames laboratoriais de pacientes
ZAMMI INSTRUMENTAL LTDA
10216359015
Apr 29, 2021
Sistema para Coleta de Amostra de Sangue
SISTEMA VAMP EDWARDS
EDWARDS LIFESCIENCES LLC
80219050172
Apr 22, 2019

